Featured News

GHTC submitted a statement, as part of the United Nations multi-stakeholder hearing on universal health coverage, calling for world leaders to provide increased public funding for R&D of health technologies.

Learn More

PATH/Gabe Bienczycki
WHO Member States Must Increase Investments in R&D for New Tools to Meet Urgent Health Challenges

Next week’s World Health Assembly will be setting priorities that have enormous life-altering implications for billions of people around the world. The Global Health Technologies Coalition (GHTC) is calling on World Health Organization (WHO) member states to increase investments in research and development (R&D), as new tools and technologies are essential for meeting urgent challenges, from achieving universal health coverage (UHC) to fighting antimicrobial resistance (AMR), including drug-resistant tuberculosis (DR-TB), and emerging threats like Ebola.

Learn More

United States Mission Geneva
GHTC director quoted in Global Health Now article highlighting issues to watch at WHA

GHTC Director Jamie Bay Nishi was quoted in a Global Health Now article previewing the issues to watch at the 72nd World Health Assembly.

View

PATH/Matthew Dakin
GHTC signs letters urging continued support for defense health research programs

GHTC endorsed letters to House and Senate appropriators from the Defense Health Research Consortium urging continued support for defense health research programs funded through the Congressionally Directed Medical Research Programs in the fiscal year 2020 budget.

PDF

PATH/Ruhani Kaur
GHTC delivers statement on access to medicines at HHS WHA listening session

GHTC delivered a statement at the US Department of Health and Human Services (HHS) World Health Assembly (WHA) Stakeholder Listening Session encouraging the US delegation to support a comprehensive approach to addressing barriers to accessing essential technologies. GHTC welcomed ongoing efforts by the World Health Organization (WHO) to strengthen regulatory systems to accelerate access and urged the US delegation to support the expansion of WHO’s Essential Diagnostic list.

Learn More

CDC/James Gathany
GHTC delivers statement on AMR at HHS WHA listening session

GHTC delivered a statement at the US Department of Health and Human Services (HHS) World Health Assembly (WHA) Stakeholder Listening Session welcoming the US government’s commitment and collaborative action, with the World Health Organization and other stakeholders, to advance development of new antimicrobials, vaccines, and diagnostics to combat antimicrobial resistance (AMR). GHTC urged the US delegation and other member states to increase investment in R&D to combat AMR and to support enhanced cooperation at all levels to tackle this growing challenge.

Learn More
View All News

PATH/Gabe Bienczycki
WHO Member States Must Increase Investments in R&D for New Tools to Meet Urgent Health Challenges

Next week’s World Health Assembly will be setting priorities that have enormous life-altering implications for billions of people around the world. The Global Health Technologies Coalition (GHTC) is calling on World Health Organization (WHO) member states to increase investments in research and development (R&D), as new tools and technologies are essential for meeting urgent challenges, from achieving universal health coverage (UHC) to fighting antimicrobial resistance (AMR), including drug-resistant tuberculosis (DR-TB), and emerging threats like Ebola.

Learn More

Flickr/Diego Cambiaso
GHTC statement on the President’s FY 2020 budget

The United States has long led the world in developing vaccines, drugs, diagnostics, and other technologies for neglected diseases and conditions that affect the world’s most vulnerable people, and the President’s budget proposal threatens to undermine this scientific and humanitarian legacy.

Learn More

PATH/Mike Wang
Global health crisis will crash G20 economy without urgent action from leaders to build new funding partnerships, warns expert report

A global coalition of charities, businesses, product development partnerships and academics have come together to say the G20 is failing to meet today’s urgent health challenges and this will only be solved if heads of government and finance ministers take charge to stop this severe threat to the global economy as well as to humanity.

Learn More

PATH/Patrick McKern
GHTC applauds passage of Global Health Innovation Act

GHTC applauds yesterday's Senate passage of the Global Health Innovation Act, a bipartisan bill to support efforts by the US Agency for International Development to develop affordable, appropriate technologies to advance the health of people in the world’s poorest places. The bill, which has already passed the House of Representatives, now heads to the President’s desk where he is expected to sign it into law.

Learn More

Senator Blunt, Rep. DeLauro, and developers of child-friendly TB medicines honored with GHTC Innovating for Impact Awards

GHTC yesterday honored Senator Roy Blunt (R-MO) and Congresswoman Rosa DeLauro (D-CT) at its second annual Innovating for Impact Awards, which celebrates US policymakers and partnerships driving progress in global health innovation. GHTC also recognized the partnership that developed and introduced improved child-friendly tuberculosis (TB) medicines, making these transformative treatments available to children in need worldwide.

Learn More
View All Announcements
PATH/Gabe Bienczycki
Research Roundup: WHO unveils online resource to guide neglected disease R&D, major funding announcements for snakebite research, and TB Alliance awarded grants to develop TB drug candidates

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Georgina Goodwin
Research Roundup: Warning to address drug-resistant TB, a new Ebola vaccine strategy in DRC, and FDA takes step to bolster research on pregnant and lactating women

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Gabe Bienczycki
Innovating the way towards UHC at WHA

Universal health coverage (UHC) will take center stage at the World Health Assembly later this month. While there are many building blocks to achieve UHC, one integral pillar that is too often overlooked is innovation—the creation of new and improved drugs, vaccines, and diagnostic tools. Global health research and development is indispensable in delivering on the vision of quality health for all.

GHTC
Read More
Global Health Technologies Coalition
Gamifying global health innovation

GHTC held a Game changers in global health game night on Capitol Hill to educate Congressional staffers about the impact of US leadership in global health research and development (R&D). Our guests ate, drank, played games, and learned how US investments in global health R&D not only saves lives around the world, but also generates benefits here at home in the United States. Here are some of our favorite photos.

Read More
PATH/Wendy Stone
Research Roundup: Study finds drugs stop HIV transmission, polio endgame strategy includes new technologies and vaccines, and FDA approves first ever vaccine for dengue fever

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
View Breakthroughs Blog

United States Mission Geneva
GHTC director quoted in Global Health Now article highlighting issues to watch at WHA

GHTC Director Jamie Bay Nishi was quoted in a Global Health Now article previewing the issues to watch at the 72nd World Health Assembly.

View

PATH/Gabe Bienczycki
GHTC commentary featured in Global Health Now

A commentary piece co-authored by GHTC’s US policy and advocacy officer on the prospects for global health funding in the fiscal year 2020 budget was featured in Global Health Now.

View

PATH/Will Boase
GHTC WHA statement cited in Homeland Preparedness News

A joint statement developed by GHTC and delivered at the 71st World Health Assembly (WHA) was cited in an article in Homeland Preparedness News.

View

PATH/Gabe Bienczycki
GHTC analysis referenced in Science

GHTC analysis regarding the implication's of the President's budget proposal on funding for the US Centers for Disease Control and Prevention was cited in an article in Science.

View

PATH/Gabe Bienczycki
GHTC advocacy on Essential Diagnostic List highlighted in Plus

GHTC's advocacy for an Essential Diagnostic List was cited in an article in Plus, an online magazine of HIV-related news.

View
View All GHTC in the Media

PATH/Matthew Dakin
GHTC signs letters urging continued support for defense health research programs

GHTC endorsed letters to House and Senate appropriators from the Defense Health Research Consortium urging continued support for defense health research programs funded through the Congressionally Directed Medical Research Programs in the fiscal year 2020 budget.

PDF

PATH/Ruhani Kaur
GHTC delivers statement on access to medicines at HHS WHA listening session

GHTC delivered a statement at the US Department of Health and Human Services (HHS) World Health Assembly (WHA) Stakeholder Listening Session encouraging the US delegation to support a comprehensive approach to addressing barriers to accessing essential technologies. GHTC welcomed ongoing efforts by the World Health Organization (WHO) to strengthen regulatory systems to accelerate access and urged the US delegation to support the expansion of WHO’s Essential Diagnostic list.

Learn More

CDC/James Gathany
GHTC delivers statement on AMR at HHS WHA listening session

GHTC delivered a statement at the US Department of Health and Human Services (HHS) World Health Assembly (WHA) Stakeholder Listening Session welcoming the US government’s commitment and collaborative action, with the World Health Organization and other stakeholders, to advance development of new antimicrobials, vaccines, and diagnostics to combat antimicrobial resistance (AMR). GHTC urged the US delegation and other member states to increase investment in R&D to combat AMR and to support enhanced cooperation at all levels to tackle this growing challenge.

Learn More

PATH/Gabe Bienczycki
GHTC submits statement for UN multi-stakeholder hearing on UHC

GHTC submitted a statement, as part of the United Nations (UN) multi-stakeholder hearing on universal health coverage (UHC), calling for world leaders to provide increased public funding for R&D of health technologies. The statement, which emphasizes the need for new and improved health tools to achieve UHC and Sustainable Development Goal 3 targets, also encourages countries to increase their commitment to research and regulatory capacity building to accelerate progress on the path to UHC.

PDF

PATH/Georgina Goodwin
GHTC sends FY20 letters to Senate appropriators

GHTC sent letters to the relevant Senate appropriations subcommittees asking them to sustain and protect global health R&D funding in the fiscal year 2020 (FY20) budget.

Learn More
View All Advocacy Actions

Events

Member Event

PATH/Doune Porter
ASTMH 68th Annual Meeting
American Society of Tropical Medicine & Hygiene
Learn More

Community Event

PATH/Eric Becker
World Infectious and Rare Diseases Congress
Scientific Future Group
Learn More
View All Current & Past Events

Stay Informed

Sign up to receive news and updates from GHTC.
Sign Up Now

Media Inquiries

Marissa Chmiola
Communications Officer
Global Health Technologies Coalition
mchmiola@ghtcoalition.org